hase III clinical trial

Advertisement

cGxPJobs Banner

Regentis Expands Phase III GelrinC Trial Across U.S. Sites

HERZLIYA, Israel, January 29, 2026 — Regentis Biomaterials Ltd. announced a significant expansion of its U.S. clinical site network...

By cGxPwire Editor
January 30, 2026

Read More

Advertisement

cGxPJobs

Directory